State Department Blog Post Discusses Research On Genetic Larvicide For Mosquitoes, Use As Tool To Prevent Zika, Other Diseases

U.S. Department of State’s “DipNote”: Targeting Mosquito Genetics to Combat Zika
Avery White, program analyst in USAID’s Center for Accelerating Innovation and Impact who helps manage the Fighting Ebola and Combating Zika and Future Threats Grand Challenges, discusses the research of Molly Duman Scheel, a professor at Indiana University developing environmentally safe larvicides for mosquitoes. White writes, “A grant from USAID’s Combating Zika and Future Threats Grand Challenge in 2016 is enabling Scheel and her team to move the larvicide testing from the lab to the field. She was one of 26 awardees who received USAID investment to accelerate innovative approaches to fight the Zika outbreak and strengthen the world’s ability to prevent, detect, and respond to future infectious disease outbreaks” (3/26).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.